Bastard et al have published fascinating research linking SARS-CoV-2 infection severity to autoantibodies against IFN (which do increase with age). I wonder if screening for antibodies against type I IFNs using ELISA (as Bastard suggests) is a suboptimal path to simple immunization.
Profile
JMA-PSOS
Syndicate
Style Credit
- Style: Neutral Good for Practicality by
![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png)
timeasmymeasure
Expand Cut Tags
No cut tags